statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Q4 2023 Cytosorbents Corp Earnings Call Transcript

CytoSorbents Corporation (CTSO) Q4 2023 Earnings Call Transcript...

CytoSorbents Corporation (CTSO) Q4 2023 Earnings Call Transcript

Recap: CytoSorbents Q4 Earnings

STAR-T trial results selected for a Breakout Presentation at the American Association of Thoracic Surgery Annual Meeting in late-April 2024 CytoSorbents intends to submit DrugSorb-ATR for regulatory...

CytoSorbents Reports Fourth Quarter and Full Year 2023 Results

PRINCETON, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...

CytoSorbents to Report Fiscal 2023 Operating and Financial Results

PRINCETON, N.J., Feb. 08, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...

CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO

NEW YORK, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cytosorbents Corporation ( Cytosorbents or the Company ) (NASDAQ: CTSO). Such investors...

NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cytosorbents Corporation ( Cytosorbents or the Company ) (NASDAQ: CTSO). Such investors...

CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.

Volume	109,450.00
52-Wk High	$4.29
52-Wk Low	$0.782

Period	Estimated	Reported	Surprise	Result
Q1'24	-$0.12	--	--	N/A
Q4'23	-$0.14	-$0.12	12.73%	BEAT
Q3'23	-$0.12	-$0.21	-70.27%	MISSED
Q2'23	-$0.11	-$0.14	-23.69%	MISSED
Q1'23	-$0.13	-$0.17	-34.21%	MISSED

CTSO Cytosorbents Corp

About

Feed

News

Sentiment

Earnings

Fundamentals